Literature DB >> 6469425

Compared effect of propranolol and acebutolol on serum thyroid hormones' levels in euthyroid and hyperthyroid patients: a randomized study.

G Perret, J N Hugues, E Modigliani, J Sebaoun.   

Abstract

An open randomized study involving 57 subjects, 40 euthyroid and 17 hyperthyreotic, was undertaken to compare the effect of two beta-adrenergic blocking drugs, propranolol (120 mg/day) and acebutolol (600 mg/day), on the thyroid hormones serum level. In hyperthyreotic as well as in euthyroid subjects, propranolol evoked a fall in T3, an increase in reverse T3 and therefore a decrease in the T3/rT3 ratio. Acebutolol caused a decrease in T3 and in the T3/rT3 ratio only in euthyroid subjects. The only significant variation in the hyperthyroid acebutolol treated group was a decrease in reverse T3, perhaps spontaneous. TBG and TSH concentrations remained stable under treatment in all the groups. The relation of these effects with the existence of a membrane stabilizing activity displayed by propranolol as well as by acebutolol is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469425

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  3 in total

1.  Acute beta-blockade changes the extracellular distribution of thyroid hormones.

Authors:  L Kayser; H Perrild; P H Petersen; L Skovsted; J E Hansen
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

2.  Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.

Authors:  D Maclean; E T Mitchell; E M Laing; F C Macdonald; K J Gough; R J Dow; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

3.  Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism.

Authors:  Lijuan Yang; Xiuqin Sun; Yi Zhao; Hong Tao
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.